RemeGen Co

RemeGen Co Dividend

Dividend of RemeGen Co (688331.SS) as of Oct 27, 2026.

Dividend

0.00CNY

Last updated:

How much dividend does RemeGen Co 2026 pay?

According to the latest status from October 2026, RemeGen Co paid a total of 0.00 CNY per share in dividends within the last 12 months. With the current RemeGen Co price of 101.17 CNY, this corresponds to a dividend yield of - %. A dividend is paid times per year.

Historical RemeGen Co Dividends

Historical RemeGen Co Dividends
PaydateDividend

The RemeGen Co Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2023
0.00 CNY
Jan 1, 2024
0.00 CNY
Jan 1, 2025
0.00 CNY
Jan 1, 2027 (e)
0.00 CNY
Jan 1, 2028 (e)
0.00 CNY
Jan 1, 2029 (e)
0.00 CNY
Jan 1, 2030 (e)
0.00 CNY
Jan 1, 2031 (e)
0.00 CNY
The RemeGen Co Dividend history
YEARDividendYoY
est0.00CNY—
est0.00CNY—
est0.00CNY—
est0.00CNY—
est0.00CNY—
0.00CNY—
0.00CNY—
0.00CNY—
0.00CNY—
0.00CNY—
0.00CNY—
0.00CNY—
0.00CNY—

Is the RemeGen Co Dividend Safe?

RemeGen Co has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Dividend Details

Understanding RemeGen Co's Dividend Distributions

RemeGen Co’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining RemeGen Co's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

RemeGen Co's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in RemeGen Co’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

RemeGen Co Stock analysis

What does RemeGen Co do? RemeGen Co Ltd generates revenue by researching, developing, and manufacturing innovative biopharmaceuticals, specifically focusing on therapeutic antibody drugs. The company's product portfolio includes tetacept (RC18), veldicitumab (RC48), and a dual-target fusion protein (RC28). These products are designed to treat major diseases such as oncology, autoimmune diseases, and ophthalmology. The firm operates primarily in the domestic market within China, where it commercializes its discoveries. Its business model relies on the development of various antibody types, including antibody drug conjugates (ADCs), antibody fusion proteins, monoclonal antibodies, and bispecific antibodies. This focus allows the company to address significant medical needs through its specialized therapeutic offerings. RemeGen Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RemeGen Co stock

RemeGen Co paid dividends every year for the past 0 years.

RemeGen Co is assigned to the 'Health' sector.

The dividends of RemeGen Co are distributed in CNY.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

All Key Metrics — RemeGen Co